Status:
COMPLETED
Treatment of Negative Symptoms and Schizophrenia
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Schizophrenia
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
PHASE2
Brief Summary
The aim of this study is to evaluate the therapeutic efficacy of a neuromodulation technique, tDCS (transcranial direct current stimulation) used as a complementary treatment on negative symptoms. 60 ...
Eligibility Criteria
Inclusion
- Schizophrenia with prominent negative symptoms
Exclusion
- other psychiatric or neurological diseases
- specific tDCS limitations
Key Trial Info
Start Date :
April 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 26 2018
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02204787
Start Date
April 1 2014
End Date
October 26 2018
Last Update
December 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UH Montpellier
Montpellier, France, 34295